L Capital Partners

News, insights, analysis and data

← Back to L Capital Partners profile

L Capital Partners related stories

All articles and analysis

  • peHUB Wire: Wednesday, April 22, 2009
    Brad Meikle- 22 April 2009

    Can Quadrangle Save Itself?

  • iScience Raises $20.5 Million
    VCJ Staff- 21 April 2009

    iScience Interventional Inc., a Menlo Park, Calif.-based developer of microcatheter technology for the treatment of ophthalmologic conditions like glaucoma and age-related macular degeneration, has raised $20.5 million in Series F funding. Affinity Capital Management led the round, and was joined by Johnson & Johnson Development Corp., L Capital Partners and Clarian Health Ventures. Return backers included Prism VentureWorks, Three Arch Ventures, DeNovo Ventures and Asset Management Co. Piper Jaffray & Co. served as a placement agent.

  • Week in deals, April 13, 2009
    Brad Meikle- 13 April 2009

    Summary of tech companies and other businesses that raised financing in North America in the past week

  • WiSpry Raises $10 Million
    VCJ Staff- 7 April 2009

    WiSpry Inc., an Irvine, Calif.-based provider of programmable RF semiconductor products for the wireless market, has held a $10 million first close on its Series C funding round. An additional $5 million in expected this summer. Paladin Capital Group led the round, and was joined by MuRata Manufacturing Co. and return backers L Capital Partners, Blueprint Ventures, American River Ventures, In-Q-Tel, Tech Coast Angels and Shepherd Ventures.

  • peHUB Wire: Tuesday, April 7, 2009
    Brad Meikle- 7 April 2009

    Random Ramblings

  • Week in deals, Nov. 24, 2008
    Brad Meikle- 24 November 2008

    Summary of tech companies and other businesses that raised financing in North America in the past week

  • Tengion Adds $21 Million for Replacement Bladders
    VCJ Staff- 19 November 2008

    Tengion Inc., an East Norriton, Penn.-based regenerative medicine company focused on replacement bladders, has raised approximately $21 million in additional Series C funding, bringing the round total to $54 million. Safeguard Scientifics was joined on the round by return backers Bain Capital, Johnson & Johnson Development Corp., Deerfield Partners, Quaker BioVentures, Oak Investment Partners, HealthCap and L Capital Partners. The company had now raised over $140 million in total VC funding.

  • PE Week Wire: Wednesday, November 19, 2008
    Brad Meikle- 19 November 2008

    Random Ramblings

  • PE Week Wire: Wednesday, November 19, 2008
    Brad Meikle- 19 November 2008

    Random Ramblings

  • Evogen Raises $3 Million
    VCJ Staff- 17 November 2008